Modular retro-vectors for transgenic and therapeutic use

Fauzia Solaiman, Mary Ann Zink, Guoping Xu, James Grunkemeyer, Dominic E Cosgrove, Jennifer Saenz, Clague P. Hodgson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Retroviruses have been used for many years as vectors for human gene therapy as well as for making transgenic animals. However, the efficient insertion of genes by retroviruses is often complicated by transcriptional inactivation of the retroviral long terminal repeats (LTRs) and by the production of replication-competent retroviruses (RCR). Solutions to these and other difficulties are being found in modular vectors, in which the desirable features of different vector systems are combined. Examples of synergistic vectors include virosomes (liposome/virus delivery), adeno-retro vectors, and MLV/VL30 chimeras. As gene delivery systems become increasingly complex, methodology is also needed for precise assembly of modular vectors. Gene self-assembly (GENSA) technology permits seamless vector construction and simultaneous, multifragment assembly. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)309-315
Number of pages7
JournalMolecular Reproduction and Development
Volume56
Issue number2 SUPPL.
StatePublished - May 23 2000

Fingerprint

Therapeutic Uses
Retroviridae
Virosomes
Gene Transfer Techniques
Genetically Modified Animals
Terminal Repeat Sequences
Insertional Mutagenesis
Liposomes
Genetic Therapy
Viruses
Technology
Genes

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology
  • Cell Biology

Cite this

Solaiman, F., Zink, M. A., Xu, G., Grunkemeyer, J., Cosgrove, D. E., Saenz, J., & Hodgson, C. P. (2000). Modular retro-vectors for transgenic and therapeutic use. Molecular Reproduction and Development, 56(2 SUPPL.), 309-315.

Modular retro-vectors for transgenic and therapeutic use. / Solaiman, Fauzia; Zink, Mary Ann; Xu, Guoping; Grunkemeyer, James; Cosgrove, Dominic E; Saenz, Jennifer; Hodgson, Clague P.

In: Molecular Reproduction and Development, Vol. 56, No. 2 SUPPL., 23.05.2000, p. 309-315.

Research output: Contribution to journalArticle

Solaiman, F, Zink, MA, Xu, G, Grunkemeyer, J, Cosgrove, DE, Saenz, J & Hodgson, CP 2000, 'Modular retro-vectors for transgenic and therapeutic use', Molecular Reproduction and Development, vol. 56, no. 2 SUPPL., pp. 309-315.
Solaiman F, Zink MA, Xu G, Grunkemeyer J, Cosgrove DE, Saenz J et al. Modular retro-vectors for transgenic and therapeutic use. Molecular Reproduction and Development. 2000 May 23;56(2 SUPPL.):309-315.
Solaiman, Fauzia ; Zink, Mary Ann ; Xu, Guoping ; Grunkemeyer, James ; Cosgrove, Dominic E ; Saenz, Jennifer ; Hodgson, Clague P. / Modular retro-vectors for transgenic and therapeutic use. In: Molecular Reproduction and Development. 2000 ; Vol. 56, No. 2 SUPPL. pp. 309-315.
@article{e10dba866fd04df59fda0e4e4c3a455f,
title = "Modular retro-vectors for transgenic and therapeutic use",
abstract = "Retroviruses have been used for many years as vectors for human gene therapy as well as for making transgenic animals. However, the efficient insertion of genes by retroviruses is often complicated by transcriptional inactivation of the retroviral long terminal repeats (LTRs) and by the production of replication-competent retroviruses (RCR). Solutions to these and other difficulties are being found in modular vectors, in which the desirable features of different vector systems are combined. Examples of synergistic vectors include virosomes (liposome/virus delivery), adeno-retro vectors, and MLV/VL30 chimeras. As gene delivery systems become increasingly complex, methodology is also needed for precise assembly of modular vectors. Gene self-assembly (GENSA) technology permits seamless vector construction and simultaneous, multifragment assembly. (C) 2000 Wiley-Liss, Inc.",
author = "Fauzia Solaiman and Zink, {Mary Ann} and Guoping Xu and James Grunkemeyer and Cosgrove, {Dominic E} and Jennifer Saenz and Hodgson, {Clague P.}",
year = "2000",
month = "5",
day = "23",
language = "English (US)",
volume = "56",
pages = "309--315",
journal = "Molecular Reproduction and Development",
issn = "1040-452X",
publisher = "Wiley-Liss Inc.",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Modular retro-vectors for transgenic and therapeutic use

AU - Solaiman, Fauzia

AU - Zink, Mary Ann

AU - Xu, Guoping

AU - Grunkemeyer, James

AU - Cosgrove, Dominic E

AU - Saenz, Jennifer

AU - Hodgson, Clague P.

PY - 2000/5/23

Y1 - 2000/5/23

N2 - Retroviruses have been used for many years as vectors for human gene therapy as well as for making transgenic animals. However, the efficient insertion of genes by retroviruses is often complicated by transcriptional inactivation of the retroviral long terminal repeats (LTRs) and by the production of replication-competent retroviruses (RCR). Solutions to these and other difficulties are being found in modular vectors, in which the desirable features of different vector systems are combined. Examples of synergistic vectors include virosomes (liposome/virus delivery), adeno-retro vectors, and MLV/VL30 chimeras. As gene delivery systems become increasingly complex, methodology is also needed for precise assembly of modular vectors. Gene self-assembly (GENSA) technology permits seamless vector construction and simultaneous, multifragment assembly. (C) 2000 Wiley-Liss, Inc.

AB - Retroviruses have been used for many years as vectors for human gene therapy as well as for making transgenic animals. However, the efficient insertion of genes by retroviruses is often complicated by transcriptional inactivation of the retroviral long terminal repeats (LTRs) and by the production of replication-competent retroviruses (RCR). Solutions to these and other difficulties are being found in modular vectors, in which the desirable features of different vector systems are combined. Examples of synergistic vectors include virosomes (liposome/virus delivery), adeno-retro vectors, and MLV/VL30 chimeras. As gene delivery systems become increasingly complex, methodology is also needed for precise assembly of modular vectors. Gene self-assembly (GENSA) technology permits seamless vector construction and simultaneous, multifragment assembly. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034066055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034066055&partnerID=8YFLogxK

M3 - Article

C2 - 10824992

AN - SCOPUS:0034066055

VL - 56

SP - 309

EP - 315

JO - Molecular Reproduction and Development

JF - Molecular Reproduction and Development

SN - 1040-452X

IS - 2 SUPPL.

ER -